In vivo MRS measurement of liver lipid levels in mice

Journal of Lipid Research

Volumn 45, Issue 7, 2004, Pages 1364-1371

  Garbow, J R ^a,b,c   Lin, X ^b   Sakata, N ^b   Chen, Z ^b   Koh, D ^a   Schonfeld, G ^b  

^a WASHINGTON UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c USA   (United States)

Author keywords

Cirrhosis; Fatty liver; Magnetic resonance spectroscopy; Triglyceride

Indexed keywords

ACCURACY; ANIMAL EXPERIMENT; ARTICLE; BAYES THEOREM; CONTROLLED STUDY; IN VIVO STUDY; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIPID STORAGE; LIVER METABOLISM; LOW FAT DIET; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; TRANSGENIC MOUSE; VALIDATION PROCESS;

ANIMALS; BAYES THEOREM; DIET; LIPIDS; LIVER; MAGNETIC RESONANCE IMAGING; MICE; MICE, TRANSGENIC; TIME FACTORS; TRIGLYCERIDES; WATER;

EID: 3042656862     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.D400001-JLR200     Document Type: Article

References (45)

1. Maher, J. 2002. Alcoholic steatosis and steatohepatitis. Semin. Gastrointest. Dis. 13: 31-39.
2. Lieber, C. 2004. New concepts of the pathogenesis of alcoholic liver disease. Curr. Gastroenterol. Rep. 6: 60-65.
3. Angulo, P. 2002. Nonalcoholic fatty liver disease. N. Engl. J. Med. 346: 1221-1231.
4. Teli, M. R., O. F. James, A. D. Burt, M. K. Bennett, and C. P. Day. 1995. The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology. 22: 1714-1719.
5. Matteoni, C. A., Z. M. Younossi, T. Gramlich, N. Boparai, Y. C. Liu, and A. J. McCullough. 1999. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 116: 1413-1419.
6. Marchesini, G., E. Bugianesi, G. Forlani, F. Cerrelli, M. Lenzi, R. Manini, S. Natale, E. Vanni, N. Villanova, N. Melchionda, and M. Rizzetto. 2003. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 37: 917-923.
7. Powell, E. E., W. G. Cooksley, R. Hanson, J. Searle, J. W. Halliday, and L. W. Powell. 1990. The natural history of nonalcoholic steato-hepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology. 11: 74-80.
8. Ikai, E., M. Ishizaki, Y. Suzuki, M. Ishida, Y. Noborizaka, and Y. Yamada. 1995. Association between hepatic steatosis, insulin resistance and hyperinsulinaemia as related to hypertension in alcohol consumers and obese people. J. Hum. Hypertens. 9: 101-105.
9. Seppala-Lindroos, A., S. Vehkavaara, A. M. Hakkinen, T. Goto, J. Westerbacka, A. Sovijarvi, J. Halavaara, and H. Yki-Jarvinen. 2002. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J. Clin. Endocrinol. Metab. 87: 3023-3028.
10. Zavaroni, I., S. Mazza, E. Dall'Aglio, P. Gasparini, M. Passeri, and G. M. Reaven. 1992. Prevalence of hyperinsulinaemia in patients with high blood pressure. J. Intern. Med. 231: 235-240.
11. Lakka, H. M., D. E. Laaksonen, T. A. Lakka, L. K. Niskanen, E. Kumpusalo, J. Tuomilehto, and J. T. Salonen. 2002. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. J. Am. Med. Assoc. 288: 2709-2716.
12. Marchesini, G., M. Brizi, A. M. Morselli-Labate, G. Bianchi, E. Bugianesi, A. J. McCullough, G. Forlani, and N. Melchionda. 1999. Association of nonalcoholic fatty liver disease with insulin resistance. Am. J. Med. 107: 450-455.
13. Reaven, G. M. 1988. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes. 37: 1595-1607.
14. Reaven, G. 2002. Metabolic syndrome: pathophysiology and implications for management of cardiovascular disease. Circulation. 106: 286-288.
15. Linton, M. F., R. V. Farese, Jr., and S. G. Young. 1993. Familial hypobetalipoproteinemia. J. Lipid Res. 34: 521-541.
16. Schonfeld, G. 1995. The hypobetalipoproteinemias. Annu. Rev. Nutr. 15: 23-34.
17. Schonfeld, G. 2003. Familial hypobetalipoproteinemia: a review. J. Lipid Res. 44: 878-883.
18. Schonfeld, G., B. W. Patterson, D. A. Yablonskiy, T. S. Tanoli, M. Averna, N. Elias, P. Yue, and J. Ackerman. 2003. Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis. J. Lipid Res. 44: 470-478.
19. Homanics, G. E., T.J. Smith, S. H. Zhang, D. Lee, S. G. Young, and N. Maeda. 1993. Targeted modification of the apolipoprotein B gene results in hypobetalipoproteinemia and developmental abnormalities in mice. Proc. Natl. Acad. Sci. USA. 90: 2389-2393.
20. Srivastava, R. A., L. Toth, N. Srivastava, M. E. Hinsdale, N. Maeda, A. B. Cefalu, M. Averna, and G. Schonfeld. 1999. Regulation of the apolipoprotein B in heterozygous hypobetalipoproteinemic knock-out mice expressing truncated apoB, B81. Low production and enhanced clearance of apoB cause low levels of apoB. Mol. Cell. Biochem. 202: 37-46.
21. Kim, E., C. M. Cham, M. M. Veniant, P. Ambroziak, and S. G. Young. 1998. Dual mechanisms for the low plasma levels of truncated apolipoprotein B proteins in familial hypobetalipoproteinemia. Analysis of a new mouse model with a nonsense mutation in the apoB gene. J. Clin. Invest. 101: 1468-1477.
22. Kim, E., P. Ambroziak, M. M. Veniant, R. L. Hamilton, and S. G. Young. 1998. A gene-targeted mouse model for familial hypobetalipoproteinemia. Low levels of apolipoprotein B mRNA in association with a nonsense mutation in exon 26 of the apolipoprotein B gene. J. Biol. Chem. 273: 33977-33984.
23. Chen, Z., R. L. Fitzgerald, M. R. Averna, and G. Schonfeld. 2000. A targeted apolipoprotein B-38.9-producing mutation causes fatty livers in mice due to the reduced ability of apolipoprotein B-38.9 to transport triglycerides. J. Biol. Chem. 275: 32807-32815.
24. Chen, Z., R. L. Fitzgerald, and G. Schonfeld. 2002. Hypobetalipoproteinemic mice with a targeted apolipoprotein (apo) B-27.6-specifying mutation: in vivo evidence for an important role of amino acids 1254-1744 of apoB in lipid transport and metabolism of the apoB-containing lipoprotein. J. Biol. Chem. 277: 14135-14145.
25. Chen, Z., R. L. Fitzgerald, G. Li, N. O. Davidson, and G. Schonfeld. 2004. Hepatic secretion of apoB-100 is impaired in hypobetalipoproteinemic mice with an apoB-38.9-specifying allele. J. Lipid Res. 45: 155-163.
26. Siegelman, E., and M. Rosen. 2001. Imaging of hepatic steatosis. Semin. Liver Dis. 21: 71-80.
27. Marcel, S., K. Lie, and C. Lam. 1995. IH-nuclear magnetic resonance spectroscopic studies of saturated, acetylenic and ethylenic triacylglycerols. Chem. Phys. Lipids. 77: 155-171.
28. 1H NMR spectroscopy of intact liver and kidney: optimization of sample preparation procedures and biochemical stability of tissue during spectral acquisition. Anal. Biochem. 282: 16-23.
29. Waters, N., E. Holmes, C. Waterfield, R. Farrant, and J. Nicholson. 2002. NMR and pattern recognition studies on liver extracts and intact livers from rats treated with α-naphthylisothiocyanate. Biochem. Pharmacol. 64: 67-77.
30. Sathasivam, N., S. Brammah, L. C. Wright, and E. J. Delikatny. 2003. Inhibition of tetraphenylphosphonium-induced NMR-visible lipid accumulation in human breast cells by chlorpromazine. Biochim. Biophys. Acta. 1633: 149-160.
31. Thomsen, C., U. Becker, K. Winkler, P. Christofferson, M. Jensen, and O. Henriksen. 1994. Quantification of liver fat using magnetic resonance spectroscopy. Magn. Reson. Imaging. 12: 487-495.
32. Longo, R., P. Pollesello, C. Ricci, F. Masutti, B. Kvam, L. Bercich, L. Croce, P. Grigolato, S. Paoletti, B. de Bernard, C. Tiribelli, and L. Dalla Palma. 1995. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J. Magn. Reson. Imaging. 5: 281-285.
33. Ricci, C., R. Longo, E. Gioulis, M. Bosco, P. Pollesello, F. Masutti, L. Croce, S. Paoletti, B. de Bernard, C. Tiribelli, and L. Dalla Palma. 1997. Noninvasive in vivo quantitative assessment of fat content in human liver. J. Hepatol. 27: 108-113.
34. Szczepaniak, L. S., E. E. Babcock, F. Schick, R. L. Dobbins, A. Garg, D. K. Burns, J. D. McGarry, and D. T. Stein. 1999. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am. J. Physiol. 276: E977-E989.
35. 1H MRS study (Abstract). Proc. Int. Soc. Magn. Reson. Med. 9: 1039.
36. Hockings, P. D., K. K. Changani, N. Saeed, D. G. Reid, J. Birmingham, P. O'Brien, J. Osborne, C. N. Toseland, and R. E. Buckingham. 2003. Rapid reversal of hepatic steatosis, and reduction of muscle triglyceride, by rosiglitazone: MRI/S studies in zucker fatty rats. Diabetes Obes. Metab. 5: 234-243.
37. Bottomley, P. A. 1987. Spatial localization in NMR spectroscopy in vivo. Ann. N. Y. Acad. Sci. 508: 333-348.
38. Garwood, M., and L. DelaBarre. 2001. The return of the frequency sweep: designing adiabatic pulses for contemporary NMR. J. Magn. Reson. 153: 155-177.
39. Tannus, A., and M. Garwood. 1997. Adiabatic pulses. NMR Biomed. 10: 423-434.
40. Neil, J., and G. Bretthorst. 1993. On the use of Bayesian probability theory for analysis of exponential decay data: an example taken from intravoxel incoherent motion experiments. Magn. Reson. Med. 29: 642-647.
41. Kotyk, J. J., N. G. Hoffman, W. C. Hutton, G. L. Bretthorst, and J. J. H. Ackerman. 1992. Comparison of Fourier and Bayesian analysis of NMR signals. I. Well-separated resonances (the single-frequency case). J. Magn. Reson. 98: 483-500.
42. Kotyk, J. J., N. G. Hoffman, W. C. Hutton, G. L. Bretthorst, and J. J. H. Ackerman. 1995. Comparison of Fourier and Bayesian analysis of signals. II. Examination of truncated free induction decay NMR data. J. Magn. Reson. Ser. A. 116: 1-9.
43. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
44. Carr, T. P., C.J. Anderson, and L. L. Rudel. 1993. Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin. Biochem. 26: 39-42.
45. Garbow, J., J. Dugas, S-K. Song, and M. Conradi. 2004. A simple, robust hardware device for passive or active respiratory gating in MRI and MRS experiments. Concepts in Magn. Reson., Part B: Magn. Reson. Engin. 21B: 40-48.